| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP13A4 TRAP1 MYH14 MYO10 SUPV3L1 CFTR KIF14 MACF1 ASCC3 DNAH5 DHX29 DNAH1 | 1.56e-05 | 614 | 88 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | serpin family protein binding | 1.92e-05 | 2 | 88 | 2 | GO:0097655 | |
| GeneOntologyMolecularFunction | cysteine-type carboxypeptidase activity | 1.15e-04 | 4 | 88 | 2 | GO:0016807 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.41e-04 | 441 | 88 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.75e-04 | 118 | 88 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | kininogen binding | 1.90e-04 | 5 | 88 | 2 | GO:0030984 | |
| GeneOntologyMolecularFunction | actin filament binding | 5.04e-04 | 227 | 88 | 6 | GO:0051015 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.77e-04 | 37 | 88 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | cysteine-type exopeptidase activity | 8.44e-04 | 10 | 88 | 2 | GO:0070004 | |
| GeneOntologyMolecularFunction | histone binding | 1.13e-03 | 265 | 88 | 6 | GO:0042393 | |
| GeneOntologyMolecularFunction | actin binding | 1.24e-03 | 479 | 88 | 8 | GO:0003779 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 1.32e-03 | 49 | 88 | 3 | GO:0005547 | |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in extracellular fluid movement | 5.56e-06 | 59 | 89 | 5 | GO:0003351 | |
| GeneOntologyBiologicalProcess | extracellular transport | 7.12e-06 | 62 | 89 | 5 | GO:0006858 | |
| GeneOntologyBiologicalProcess | regulation of cell shape | 6.55e-05 | 159 | 89 | 6 | GO:0008360 | |
| GeneOntologyCellularComponent | cell cortex | SPTBN5 PTK2B TCHP MYO10 INSC SPTB SPTBN2 MACF1 MARK2 SLC4A1 EXOC4 | 5.64e-07 | 371 | 90 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | spectrin | 6.36e-06 | 9 | 90 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | apical cortex | 9.06e-06 | 10 | 90 | 3 | GO:0045179 | |
| GeneOntologyCellularComponent | cis-Golgi network | 3.31e-05 | 85 | 90 | 5 | GO:0005801 | |
| GeneOntologyCellularComponent | cell cortex region | 4.18e-05 | 45 | 90 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.99e-04 | 278 | 90 | 7 | GO:0098858 | |
| GeneOntologyCellularComponent | cilium | SPTBN5 AKAP9 TCHP MROH2B CEP250 CFAP43 USP48 DNAH5 QRICH2 SPAG5 INVS DNAH1 | 4.60e-04 | 898 | 90 | 12 | GO:0005929 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 5.74e-04 | 238 | 90 | 6 | GO:0097729 | |
| GeneOntologyCellularComponent | cell body | GHRH CACNA1A PTK2B AKAP9 MYO10 SPTBN2 CFTR RESP18 PLXND1 CTSL CTSV EXOC4 | 6.22e-04 | 929 | 90 | 12 | GO:0044297 |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 6.47e-04 | 9 | 90 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | Golgi stack | 8.67e-04 | 171 | 90 | 5 | GO:0005795 | |
| GeneOntologyCellularComponent | neuronal cell body | GHRH CACNA1A PTK2B AKAP9 MYO10 SPTBN2 CFTR RESP18 CTSL CTSV EXOC4 | 9.06e-04 | 835 | 90 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | cytoplasmic region | 9.31e-04 | 360 | 90 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | insulin-responsive compartment | 9.83e-04 | 11 | 90 | 2 | GO:0032593 | |
| GeneOntologyCellularComponent | microvillus | 1.97e-03 | 123 | 90 | 4 | GO:0005902 | |
| MousePheno | abnormal R wave | 4.71e-06 | 7 | 73 | 3 | MP:0011919 | |
| MousePheno | abnormal T wave | 1.12e-05 | 9 | 73 | 3 | MP:0010505 | |
| MousePheno | periodontal ligament necrosis | 2.69e-05 | 2 | 73 | 2 | MP:0030515 | |
| MousePheno | abnormal lymph node medullary sinus morphology | 2.69e-05 | 2 | 73 | 2 | MP:0011222 | |
| MousePheno | dilated lymph node medullary sinus | 2.69e-05 | 2 | 73 | 2 | MP:0011223 | |
| MousePheno | abnormal heart atrium morphology | 2.71e-05 | 232 | 73 | 8 | MP:0003105 | |
| MousePheno | increased heart atrium size | 9.46e-05 | 46 | 73 | 4 | MP:0008725 | |
| MousePheno | abnormal heart echocardiography feature | 1.21e-04 | 49 | 73 | 4 | MP:0011925 | |
| MousePheno | abnormal ion homeostasis | PHEX PTK2B TRAP1 AKAP9 PIK3CD SPTB SPTBN2 CFTR BAZ1B RESP18 KCTD1 ASCC3 ECPAS DNAH5 GIMAP6 SLC4A1 EXOC4 | 1.59e-04 | 1232 | 73 | 17 | MP:0001765 |
| MousePheno | abnormal respiratory epithelial transmembrane transport | 1.60e-04 | 4 | 73 | 2 | MP:0014026 | |
| MousePheno | abnormal heart atrium size | 1.78e-04 | 54 | 73 | 4 | MP:0031576 | |
| MousePheno | abnormal calcium ion homeostasis | 2.43e-04 | 404 | 73 | 9 | MP:0004231 | |
| MousePheno | folliculitis | 2.66e-04 | 5 | 73 | 2 | MP:0000376 | |
| MousePheno | dental pulp necrosis | 2.66e-04 | 5 | 73 | 2 | MP:0013251 | |
| MousePheno | hair follicle outer root sheath hyperplasia | 2.66e-04 | 5 | 73 | 2 | MP:0010688 | |
| MousePheno | enlarged thymus cortex | 2.66e-04 | 5 | 73 | 2 | MP:0013593 | |
| MousePheno | increased circulating mineral level | SPTB SPTBN2 BAZ1B RESP18 KCTD1 ASCC3 ECPAS DNAH5 GIMAP6 SLC4A1 EXOC4 | 3.77e-04 | 626 | 73 | 11 | MP:0014547 |
| Domain | Spectrin_repeat | 3.74e-09 | 29 | 87 | 6 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 7.05e-09 | 32 | 87 | 6 | IPR018159 | |
| Domain | SPEC | 7.05e-09 | 32 | 87 | 6 | SM00150 | |
| Domain | Actinin_actin-bd_CS | 6.15e-08 | 23 | 87 | 5 | IPR001589 | |
| Domain | Spectrin | 6.15e-08 | 23 | 87 | 5 | PF00435 | |
| Domain | ACTININ_2 | 6.15e-08 | 23 | 87 | 5 | PS00020 | |
| Domain | ACTININ_1 | 6.15e-08 | 23 | 87 | 5 | PS00019 | |
| Domain | CH | 5.68e-07 | 65 | 87 | 6 | SM00033 | |
| Domain | CH | 8.86e-07 | 70 | 87 | 6 | PF00307 | |
| Domain | - | 9.64e-07 | 71 | 87 | 6 | 1.10.418.10 | |
| Domain | CH | 1.14e-06 | 73 | 87 | 6 | PS50021 | |
| Domain | CH-domain | 1.34e-06 | 75 | 87 | 6 | IPR001715 | |
| Domain | DUF4795 | 2.14e-05 | 2 | 87 | 2 | IPR032013 | |
| Domain | DUF4795 | 2.14e-05 | 2 | 87 | 2 | PF16043 | |
| Domain | MRFAP1 | 2.14e-05 | 2 | 87 | 2 | IPR029254 | |
| Domain | MRFAP1 | 2.14e-05 | 2 | 87 | 2 | PF15155 | |
| Domain | Spectrin_bsu | 1.28e-04 | 4 | 87 | 2 | IPR016343 | |
| Domain | NUT | 2.13e-04 | 5 | 87 | 2 | IPR024310 | |
| Domain | NUT_N | 2.13e-04 | 5 | 87 | 2 | IPR024309 | |
| Domain | NUT | 2.13e-04 | 5 | 87 | 2 | PF12881 | |
| Domain | GOLGA6L | 3.18e-04 | 6 | 87 | 2 | IPR026737 | |
| Domain | - | 3.18e-04 | 6 | 87 | 2 | 3.90.1290.10 | |
| Domain | Plectin_repeat | 4.44e-04 | 7 | 87 | 2 | IPR001101 | |
| Domain | Inhibitor_I29 | 4.44e-04 | 7 | 87 | 2 | PF08246 | |
| Domain | Prot_inhib_I29 | 4.44e-04 | 7 | 87 | 2 | IPR013201 | |
| Domain | Inhibitor_I29 | 4.44e-04 | 7 | 87 | 2 | SM00848 | |
| Domain | Plectin | 4.44e-04 | 7 | 87 | 2 | PF00681 | |
| Domain | PLEC | 4.44e-04 | 7 | 87 | 2 | SM00250 | |
| Domain | PH_dom-spectrin-type | 7.56e-04 | 9 | 87 | 2 | IPR001605 | |
| Domain | Pept_asp_AS | 9.42e-04 | 10 | 87 | 2 | IPR025661 | |
| Domain | Pept_his_AS | 1.15e-03 | 11 | 87 | 2 | IPR025660 | |
| Domain | FERM_M | 1.28e-03 | 46 | 87 | 3 | PF00373 | |
| Domain | - | 1.54e-03 | 49 | 87 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 1.54e-03 | 49 | 87 | 3 | IPR019748 | |
| Domain | FERM_domain | 1.54e-03 | 49 | 87 | 3 | IPR000299 | |
| Domain | Pept_C1 | 1.62e-03 | 13 | 87 | 2 | SM00645 | |
| Domain | Peptidase_C1A_C | 1.62e-03 | 13 | 87 | 2 | IPR000668 | |
| Domain | Peptidase_C1 | 1.62e-03 | 13 | 87 | 2 | PF00112 | |
| Domain | Peptidase_C1A | 1.62e-03 | 13 | 87 | 2 | IPR013128 | |
| Domain | FERM_1 | 1.63e-03 | 50 | 87 | 3 | PS00660 | |
| Domain | FERM_2 | 1.63e-03 | 50 | 87 | 3 | PS00661 | |
| Domain | FERM_3 | 1.63e-03 | 50 | 87 | 3 | PS50057 | |
| Domain | Band_41_domain | 1.63e-03 | 50 | 87 | 3 | IPR019749 | |
| Domain | B41 | 1.63e-03 | 50 | 87 | 3 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.63e-03 | 50 | 87 | 3 | IPR014352 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.88e-03 | 14 | 87 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.88e-03 | 14 | 87 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.88e-03 | 14 | 87 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.88e-03 | 14 | 87 | 2 | PF08393 | |
| Domain | MT | 1.88e-03 | 14 | 87 | 2 | PF12777 | |
| Domain | AAA_8 | 1.88e-03 | 14 | 87 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.88e-03 | 14 | 87 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.88e-03 | 14 | 87 | 2 | PF07728 | |
| Domain | P-loop_NTPase | SBNO1 MYH14 MYO10 SUPV3L1 CFTR KIF14 ASCC3 DNAH5 DHX29 GIMAP6 DNAH1 | 1.90e-03 | 848 | 87 | 11 | IPR027417 |
| Domain | DHC_fam | 2.17e-03 | 15 | 87 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.17e-03 | 15 | 87 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.17e-03 | 15 | 87 | 2 | PF03028 | |
| Domain | Pkinase_Tyr | 3.11e-03 | 129 | 87 | 4 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.95e-03 | 138 | 87 | 4 | IPR001245 | |
| Domain | PH | 4.34e-03 | 229 | 87 | 5 | PF00169 | |
| Domain | IQ | 4.44e-03 | 71 | 87 | 3 | PF00612 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 9.98e-06 | 10 | 63 | 3 | MM15112 | |
| Pubmed | EHBP1 L3MBTL2 DSP KIF14 ASCC3 ECPAS UTRN DENND4C SPAG5 EXOC4 | 1.69e-07 | 418 | 92 | 10 | 34709266 | |
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | GOLGA8DP PTK2B SELENOS SPATA31E1 L3MBTL2 SBNO1 GOLGA8CP MRFAP1 SPTB MARK2 | 3.33e-07 | 450 | 92 | 10 | 16751776 |
| Pubmed | 1.81e-06 | 216 | 92 | 7 | 31519766 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EHBP1 PTK2B GBF1 AKAP9 DSP KIF14 MACF1 MARK2 MAP3K21 UTRN DENND4C EXOC4 | 2.90e-06 | 861 | 92 | 12 | 36931259 |
| Pubmed | 2.94e-06 | 446 | 92 | 9 | 24255178 | ||
| Pubmed | 2.94e-06 | 332 | 92 | 8 | 37433992 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | TRAP1 MYH14 UBTF SUPV3L1 SPTB SPTBN2 LEMD2 KIF14 MSANTD4 KCTD1 MARK2 | 3.82e-06 | 732 | 92 | 11 | 34732716 |
| Pubmed | 4.27e-06 | 90 | 92 | 5 | 15033168 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | GBF1 AKAP9 L3MBTL2 TCHP MYH14 MYO10 SUPV3L1 CEP250 BAZ1B NUTM2F GIMAP6 PABIR3 DENND4C NUTM2G | 4.78e-06 | 1242 | 92 | 14 | 30973865 |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 18796539 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 19801522 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 36735789 | ||
| Pubmed | Cathepsin L plays an active role in involution of the mouse mammary gland. | 6.92e-06 | 2 | 92 | 2 | 12815617 | |
| Pubmed | Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury. | 6.92e-06 | 2 | 92 | 2 | 28332696 | |
| Pubmed | Impaired turnover of autophagolysosomes in cathepsin L deficiency. | 6.92e-06 | 2 | 92 | 2 | 20536383 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16621972 | ||
| Pubmed | Cathepsin L regulates pathogenicCD4 T cells in experimental autoimmune encephalomyelitis. | 6.92e-06 | 2 | 92 | 2 | 33540247 | |
| Pubmed | The protease cathepsin L regulates Th17 cell differentiation. | 6.92e-06 | 2 | 92 | 2 | 26343333 | |
| Pubmed | Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice. | 6.92e-06 | 2 | 92 | 2 | 16636100 | |
| Pubmed | Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation. | 6.92e-06 | 2 | 92 | 2 | 31010818 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 20338168 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 27586811 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 23912553 | ||
| Pubmed | Cathepsin L Helps to Defend Mice from Infection with Influenza A. | 6.92e-06 | 2 | 92 | 2 | 27716790 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16393949 | ||
| Pubmed | Cathepsin L in bone marrow-derived cells is required for retinal and choroidal neovascularization. | 6.92e-06 | 2 | 92 | 2 | 20304958 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11978977 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 2275556 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11398968 | ||
| Pubmed | A variant of pulmonary alveolar microlithiasis in nackt mice. | 6.92e-06 | 2 | 92 | 2 | 12014504 | |
| Pubmed | Utilization of spectrins βI and βIII in diagnosis of hepatocellular carcinoma. | 6.92e-06 | 2 | 92 | 2 | 30798076 | |
| Pubmed | Cathepsin L protects mice from mycoplasmal infection and is essential for airway lymphangiogenesis. | 6.92e-06 | 2 | 92 | 2 | 23600672 | |
| Pubmed | Mice that express enzymatically inactive cathepsin L exhibit abnormal spermatogenesis. | 6.92e-06 | 2 | 92 | 2 | 12533435 | |
| Pubmed | Cathepsin L was involved in vascular aging by mediating phenotypic transformation of vascular cells. | 6.92e-06 | 2 | 92 | 2 | 36206719 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12466121 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 3689328 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 10516062 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 19096818 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11023992 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 17671649 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 3755373 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 21434350 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 21972973 | ||
| Pubmed | Cell type-specific functions of the lysosomal protease cathepsin L in the heart. | 6.92e-06 | 2 | 92 | 2 | 17942402 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16705169 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15679121 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 2835398 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 8554545 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 19589362 | ||
| Pubmed | Cathepsin L is essential for onset of autoimmune diabetes in NOD mice. | 6.92e-06 | 2 | 92 | 2 | 16184198 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16079282 | ||
| Pubmed | Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice. | 6.92e-06 | 2 | 92 | 2 | 21868704 | |
| Pubmed | Cathepsin-L contributes to cardiac repair and remodelling post-infarction. | 6.92e-06 | 2 | 92 | 2 | 21147810 | |
| Pubmed | Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. | 6.92e-06 | 2 | 92 | 2 | 18957203 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11022031 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 23585893 | ||
| Pubmed | Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. | 6.92e-06 | 2 | 92 | 2 | 9545226 | |
| Pubmed | Cathepsin L gene expression and promoter activation in rodent granulosa cells. | 6.92e-06 | 2 | 92 | 2 | 14563703 | |
| Pubmed | Cathepsin L is crucial for the development of early experimental diabetic nephropathy. | 6.92e-06 | 2 | 92 | 2 | 27575559 | |
| Pubmed | Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. | 6.92e-06 | 2 | 92 | 2 | 11972068 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 20877570 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 19900452 | ||
| Pubmed | Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression. | 6.92e-06 | 2 | 92 | 2 | 25957406 | |
| Pubmed | Cloning, genomic organization, and chromosomal localization of human cathepsin L. | 6.92e-06 | 2 | 92 | 2 | 8419312 | |
| Pubmed | Thymocyte expression of cathepsin L is essential for NKT cell development. | 6.92e-06 | 2 | 92 | 2 | 12368909 | |
| Pubmed | Cloning and characterization of a mouse cysteine proteinase. | 6.92e-06 | 2 | 92 | 2 | 3533924 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 1482371 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12163394 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 20347002 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15154914 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 23608608 | ||
| Pubmed | Developmental expression of cathepsin L and c-rasHa in the mouse placenta. | 6.92e-06 | 2 | 92 | 2 | 1751032 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 29154036 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 31771567 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15070709 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12054558 | ||
| Pubmed | Cathepsin L is involved in proliferation and invasion of breast cancer cells. | 6.92e-06 | 2 | 92 | 2 | 26639231 | |
| Pubmed | An alternate targeting pathway for procathepsin L in mouse fibroblasts. | 6.92e-06 | 2 | 92 | 2 | 11929604 | |
| Pubmed | Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis. | 6.92e-06 | 2 | 92 | 2 | 20023699 | |
| Pubmed | Impaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes. | 6.92e-06 | 2 | 92 | 2 | 12941783 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12000732 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15905545 | ||
| Pubmed | Alterations during positive selection in the thymus of nackt CD4-deficient mice. | 6.92e-06 | 2 | 92 | 2 | 11119260 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 19852935 | ||
| Pubmed | Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels. | 6.92e-06 | 2 | 92 | 2 | 18469859 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 32457751 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 2826441 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 38329128 | ||
| Pubmed | TARS3 SBNO1 DSP MYH14 SUPV3L1 MRFAP1 SPTB SPTBN2 MACF1 ZNF224 UTRN CTSL MRFAP1L1 EXOC4 | 7.04e-06 | 1285 | 92 | 14 | 35914814 | |
| Pubmed | AKAP9 L3MBTL2 TCHP UBTF FARP1 SPTBN2 BAZ1B MACF1 FASTKD2 ADI1 MARK2 ASCC3 USP48 DHX29 EXOC4 | 8.04e-06 | 1487 | 92 | 15 | 33957083 | |
| Pubmed | TCHP MYH14 MRFAP1 KIF14 MPHOSPH8 USP48 UTRN DENND4C SPAG5 EXOC4 | 8.27e-06 | 645 | 92 | 10 | 25281560 | |
| Pubmed | 9.20e-06 | 653 | 92 | 10 | 22586326 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 1.42e-05 | 18 | 92 | 3 | 12119179 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.74e-05 | 120 | 92 | 5 | 31413325 | |
| Pubmed | EHBP1 DSP MACF1 MARK2 ASCC3 ECPAS MAP3K21 DHX29 DENND4C EXOC4 | 1.84e-05 | 708 | 92 | 10 | 39231216 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 18362148 | ||
| Pubmed | The PI3K regulatory subunits p55α and p50α regulate cell death in vivo. | 2.07e-05 | 3 | 92 | 2 | 24902901 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 23233448 | ||
| Pubmed | Cathepsin L activity controls adipogenesis and glucose tolerance. | 2.07e-05 | 3 | 92 | 2 | 17643114 | |
| Pubmed | Invariant chain controls the activity of extracellular cathepsin L. | 2.07e-05 | 3 | 92 | 2 | 12417635 | |
| Interaction | PHF21A interactions | EHBP1 L3MBTL2 DSP KIF14 ASCC3 ECPAS UTRN DENND4C SPAG5 EXOC4 | 3.39e-06 | 343 | 91 | 10 | int:PHF21A |
| Interaction | PHLDB2 interactions | 3.85e-06 | 143 | 91 | 7 | int:PHLDB2 | |
| Interaction | APC interactions | 1.02e-05 | 389 | 91 | 10 | int:APC | |
| Interaction | CAMSAP2 interactions | 1.15e-05 | 169 | 91 | 7 | int:CAMSAP2 | |
| Interaction | PCNT interactions | 1.35e-05 | 241 | 91 | 8 | int:PCNT | |
| Interaction | CEP170 interactions | 1.37e-05 | 318 | 91 | 9 | int:CEP170 | |
| Interaction | LCK interactions | 4.53e-05 | 463 | 91 | 10 | int:LCK | |
| Interaction | RHOF interactions | PIKFYVE EHBP1 GBF1 FARP1 SPTBN2 KIF14 MACF1 FASTKD2 MARK2 ECPAS UTRN DENND4C | 4.93e-05 | 673 | 91 | 12 | int:RHOF |
| Interaction | FLOT1 interactions | 5.62e-05 | 475 | 91 | 10 | int:FLOT1 | |
| Interaction | GOLGA6L6 interactions | 6.03e-05 | 3 | 91 | 2 | int:GOLGA6L6 | |
| Interaction | DCTN1 interactions | 8.18e-05 | 497 | 91 | 10 | int:DCTN1 | |
| Interaction | MAPRE3 interactions | 8.26e-05 | 230 | 91 | 7 | int:MAPRE3 | |
| Interaction | LYN interactions | EHBP1 PTK2B DSP FARP1 SPTBN2 KIF14 MACF1 MARK2 MAP3K21 UTRN DENND4C SLC4A1 | 9.39e-05 | 720 | 91 | 12 | int:LYN |
| Interaction | GSDME interactions | 9.62e-05 | 53 | 91 | 4 | int:GSDME | |
| Interaction | SEC16A interactions | 1.31e-04 | 426 | 91 | 9 | int:SEC16A | |
| Interaction | UBR4 interactions | 1.35e-04 | 334 | 91 | 8 | int:UBR4 | |
| Interaction | CAPZA2 interactions | 1.41e-04 | 430 | 91 | 9 | int:CAPZA2 | |
| Interaction | PCM1 interactions | 1.51e-04 | 434 | 91 | 9 | int:PCM1 | |
| Interaction | AURKB interactions | TARS3 TRAP1 GBF1 MAN2B1 DSP MYH14 KIF14 MACF1 MARK2 USP48 UTRN SPAG5 | 1.58e-04 | 761 | 91 | 12 | int:AURKB |
| Interaction | GBF1 interactions | 1.73e-04 | 442 | 91 | 9 | int:GBF1 | |
| Interaction | OFD1 interactions | 1.75e-04 | 347 | 91 | 8 | int:OFD1 | |
| Interaction | CTCFL interactions | 1.78e-04 | 62 | 91 | 4 | int:CTCFL | |
| Interaction | CLIP1 interactions | 1.82e-04 | 183 | 91 | 6 | int:CLIP1 | |
| Interaction | GOLGA1 interactions | 1.82e-04 | 183 | 91 | 6 | int:GOLGA1 | |
| Cytoband | 15q11.2 | 4.11e-04 | 172 | 92 | 4 | 15q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q22 | 7.24e-04 | 200 | 92 | 4 | chr9q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q11 | 9.80e-04 | 217 | 92 | 4 | chr15q11 | |
| Cytoband | 12q24.11 | 2.01e-03 | 33 | 92 | 2 | 12q24.11 | |
| GeneFamily | EF-hand domain containing|Spectrins | 9.24e-07 | 7 | 55 | 3 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.51e-04 | 8 | 55 | 2 | 939 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.01e-04 | 206 | 55 | 5 | 682 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 4.72e-04 | 50 | 55 | 3 | 1293 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 4.91e-04 | 11 | 55 | 2 | 1168 | |
| GeneFamily | Cathepsins | 9.30e-04 | 15 | 55 | 2 | 470 | |
| GeneFamily | Dyneins, axonemal | 1.20e-03 | 17 | 55 | 2 | 536 | |
| GeneFamily | Ankyrin repeat domain containing | 6.26e-03 | 242 | 55 | 4 | 403 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.86e-07 | 180 | 89 | 8 | M8239 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.37e-06 | 185 | 92 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.85e-06 | 191 | 92 | 6 | 9bb6a6b88f351217455765ba07a6acf11fda98f4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.94e-06 | 192 | 92 | 6 | 1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 195 | 92 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 197 | 92 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.41e-05 | 148 | 92 | 5 | d5cace5605bff2bb8248fadb51f2dad7539930ba | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-05 | 154 | 92 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-05 | 154 | 92 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-05 | 155 | 92 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-05 | 155 | 92 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 164 | 92 | 5 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-05 | 164 | 92 | 5 | 29da0175bd3808a5b3039a6161c764105608ef96 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-05 | 164 | 92 | 5 | e83b632ac7e1dace946991ddfe1fbfbbffc3a88b | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-05 | 165 | 92 | 5 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-05 | 165 | 92 | 5 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-05 | 175 | 92 | 5 | 8362a46f5804333baa84cd56d450bc147f372a7e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-05 | 175 | 92 | 5 | 8b4c62e608f0ec84e563bbf0ebffe3ed44085298 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 178 | 92 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.69e-05 | 181 | 92 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 3.99e-05 | 184 | 92 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 185 | 92 | 5 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 4.10e-05 | 185 | 92 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 185 | 92 | 5 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-05 | 186 | 92 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 4.21e-05 | 186 | 92 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 4.31e-05 | 187 | 92 | 5 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-05 | 187 | 92 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 4.42e-05 | 188 | 92 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 189 | 92 | 5 | a9864873b19ab3e60acf11f288fa7275badc2e42 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 189 | 92 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | droplet-Lung-nan-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 190 | 92 | 5 | b057bea6e55cef872290893b6e439bbcdcee2f2e | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 4.77e-05 | 191 | 92 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 191 | 92 | 5 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 191 | 92 | 5 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-05 | 191 | 92 | 5 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 194 | 92 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.14e-05 | 194 | 92 | 5 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | BL-critical-LOC-Epithelial-unknown_epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.14e-05 | 194 | 92 | 5 | 6140ff8e776429c9593607da418b2d9c4f399d41 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 195 | 92 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.52e-05 | 197 | 92 | 5 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 5.52e-05 | 197 | 92 | 5 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 5.52e-05 | 197 | 92 | 5 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.66e-05 | 198 | 92 | 5 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.66e-05 | 198 | 92 | 5 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.66e-05 | 198 | 92 | 5 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.66e-05 | 198 | 92 | 5 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.79e-05 | 199 | 92 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.79e-05 | 199 | 92 | 5 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.79e-05 | 199 | 92 | 5 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | distal-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.93e-05 | 200 | 92 | 5 | 2fc1e95706f212bf18ecdf6eb5b3182ac98c9b52 | |
| ToppCell | medial-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.93e-05 | 200 | 92 | 5 | 0079041c3e654c1ef77c492bdb2f31ce8f4b507b | |
| ToppCell | Biopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type | 5.93e-05 | 200 | 92 | 5 | 76f1ac00b34d07057d8da03d276438b719b46b1d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | medial-Epithelial|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.93e-05 | 200 | 92 | 5 | 17bb9a9016058cbb70c7bd894c12f6208ff07895 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 126 | 92 | 4 | 4eeea015efe17e0aae5bd76b71fa70b5149dfada | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.14e-04 | 142 | 92 | 4 | 369f2e51e0283a4de70e6c7a3b95672c0838f205 | |
| ToppCell | ASK454-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.69e-04 | 12 | 92 | 2 | f8ea75314b9fa2bdc57564cad9640893a47f0340 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.71e-04 | 151 | 92 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.71e-04 | 151 | 92 | 4 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.71e-04 | 151 | 92 | 4 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | facs-Aorta-Heart-24m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 152 | 92 | 4 | 525d65c5c8e5580947367afdb1f6e68b49e9e5bb | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-04 | 154 | 92 | 4 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-04 | 154 | 92 | 4 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 3.07e-04 | 156 | 92 | 4 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 158 | 92 | 4 | 9fd77ebdd1babf1c85a85d38d9a15858ab08bc84 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 158 | 92 | 4 | 0edd9b005875f9a4f5446f5d5161f8ba63860793 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.29e-04 | 159 | 92 | 4 | a082e770fa757c4a1d3ed13d53f83297e36faf05 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-04 | 160 | 92 | 4 | 9f24ee4fe1ba4590dce5dd4d43707fb007dca82f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-04 | 160 | 92 | 4 | 7064af50fc10e3ea03badf415306222b74db0f95 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-04 | 160 | 92 | 4 | 3b3b99305558f5b49d050fb9b249007630ea9085 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-04 | 160 | 92 | 4 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-04 | 160 | 92 | 4 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.45e-04 | 161 | 92 | 4 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.70e-04 | 164 | 92 | 4 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.70e-04 | 164 | 92 | 4 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.70e-04 | 164 | 92 | 4 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 165 | 92 | 4 | 361a605d8f833d9ec54b120480dce397da35f9c3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.88e-04 | 166 | 92 | 4 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 3.97e-04 | 167 | 92 | 4 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-04 | 167 | 92 | 4 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-04 | 167 | 92 | 4 | fcd583b1efd0ac883379982ea8e6c54f2c0be268 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-04 | 167 | 92 | 4 | f6bc63138b7239211fa5f27a8dc799b6e022c0f8 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-04 | 167 | 92 | 4 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.06e-04 | 168 | 92 | 4 | 32e4d82efaccf336d347e4063253c3635a3ec672 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.06e-04 | 168 | 92 | 4 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 4.15e-04 | 169 | 92 | 4 | 425d89ab69e9f9eb3df84056676423e390cc6ab1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-04 | 169 | 92 | 4 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-04 | 169 | 92 | 4 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.34e-04 | 171 | 92 | 4 | a8adce007ff4c713f71f2359b40cb3575b28c98d | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.34e-04 | 171 | 92 | 4 | d339840626211a7bf1a9eb8f14d6c9509ab05e1c | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.34e-04 | 171 | 92 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.34e-04 | 171 | 92 | 4 | f1fdc0ec3399ed6955976d02be7e5fc329a64276 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 173 | 92 | 4 | 27ae126c720f20d1fe116abbcd358e4cff8baf6b | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 173 | 92 | 4 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 173 | 92 | 4 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 173 | 92 | 4 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-04 | 174 | 92 | 4 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| Drug | AC1L1DW2 | 7.47e-07 | 186 | 90 | 8 | CID000002532 | |
| Drug | plakin | 8.87e-07 | 82 | 90 | 6 | CID000018752 | |
| Drug | dimyristoylphosphatidylcholine | 5.47e-06 | 64 | 90 | 5 | CID000026197 | |
| Disease | Bronchiectasis | 3.30e-05 | 22 | 84 | 3 | C0006267 | |
| Disease | Elliptocytosis found | 4.79e-05 | 4 | 84 | 2 | C0427480 | |
| Disease | Hereditary elliptocytosis | 4.79e-05 | 4 | 84 | 2 | cv:C0013902 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 4.79e-05 | 4 | 84 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Anemia, hereditary spherocytic hemolytic | 7.96e-05 | 5 | 84 | 2 | C0221409 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 7.96e-05 | 5 | 84 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 7.96e-05 | 5 | 84 | 2 | cv:C0037889 | |
| Disease | Elliptocytosis, Hereditary | 1.19e-04 | 6 | 84 | 2 | C0013902 | |
| Disease | Hereditary spherocytosis | 2.22e-04 | 8 | 84 | 2 | C0037889 | |
| Disease | household income | 2.36e-04 | 304 | 84 | 6 | EFO_0009695 | |
| Disease | frontal fibrosing alopecia | 3.51e-04 | 48 | 84 | 3 | EFO_0009855 | |
| Disease | Dental enamel hypoplasia | 5.19e-04 | 12 | 84 | 2 | EFO_1001304 | |
| Disease | migraine disorder | 5.53e-04 | 357 | 84 | 6 | MONDO_0005277 | |
| Disease | Anemia, Hemolytic, Acquired | 6.12e-04 | 13 | 84 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 6.12e-04 | 13 | 84 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 6.12e-04 | 13 | 84 | 2 | C0002889 | |
| Disease | Microangiopathic hemolytic anemia | 6.12e-04 | 13 | 84 | 2 | C0221021 | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 7.13e-04 | 14 | 84 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | cathepsin L1 measurement | 9.36e-04 | 16 | 84 | 2 | EFO_0010619 | |
| Disease | unipolar depression, bipolar disorder | 1.04e-03 | 156 | 84 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | otitis media (biomarker_via_orthology) | 1.06e-03 | 17 | 84 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | Dermatologic disorders | 1.30e-03 | 75 | 84 | 3 | C0037274 | |
| Disease | depressive symptom measurement | 1.38e-03 | 426 | 84 | 6 | EFO_0007006 | |
| Disease | otitis media (implicated_via_orthology) | 1.78e-03 | 22 | 84 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | triacylglycerol 58:9 measurement | 1.78e-03 | 22 | 84 | 2 | EFO_0010443 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 2.12e-03 | 24 | 84 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | ergothioneine measurement | 2.49e-03 | 26 | 84 | 2 | EFO_0021163 | |
| Disease | cystic fibrosis (is_implicated_in) | 2.68e-03 | 27 | 84 | 2 | DOID:1485 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQMDAELRKEMMAIW | 1916 | O00555 | |
| NMVMKLEEQIRWYRQ | 3611 | Q99996 | |
| RILQIEWEHKKMEME | 1496 | Q8NDM7 | |
| EWEHKKMEMEREDLN | 1501 | Q8NDM7 | |
| KMEMEREDLNQKAWD | 1506 | Q8NDM7 | |
| KQKWQEMEMRDLQRL | 426 | Q8NFR7 | |
| CWEEAMEKMIENLRQ | 276 | P13569 | |
| MDEKNQELRWMEAAR | 66 | P02730 | |
| REQELREMAWSTMKQ | 286 | O00481 | |
| VWEKNMKMIELHNGE | 51 | O60911 | |
| EEAVIENRALWMMIK | 1126 | Q4VNC1 | |
| METRQQMSAELWKER | 766 | Q9UIG0 | |
| EAQQMVDLMKRCWDQ | 256 | Q8NFD2 | |
| LRQLRMWKMQLLDEN | 326 | Q7L5Y6 | |
| EEKNMEVNMKEWILR | 221 | Q7Z478 | |
| DWQKMLDRLLTEMDN | 1361 | Q9H0J4 | |
| MEWKLEQSMREQALL | 1 | Q08AF8 | |
| KLWEMDNMLIQIKTQ | 56 | Q96HT8 | |
| MDLINRETMSEWKLQ | 86 | Q6P4D5 | |
| LQREKDWVSKIQMMQ | 406 | Q86TB9 | |
| HQQERDMAEMQRVWK | 756 | Q15058 | |
| DMAEMQRVWKEKFEQ | 761 | Q15058 | |
| WRKLEEEEQAMYEMV | 401 | Q8NC56 | |
| QWEDVMKGMKVEVLN | 206 | Q969R5 | |
| EWIKSLMNNSKEEMR | 696 | Q5VYK3 | |
| KMQAQMKELWREVEE | 1666 | Q7Z406 | |
| ERYWQKTLLQMEEME | 1301 | Q9Y4D7 | |
| QLQPMLLEMERWKQD | 116 | Q719H9 | |
| QKVEEEQMLDMWIKE | 1901 | Q9HD67 | |
| QEQEEKMWEQEEKMR | 351 | Q8N9W4 | |
| ERMREQEKMWEQVEK | 411 | Q8N9W4 | |
| QEEMMWEKEEKIREL | 356 | A8MZA4 | |
| KMWRQEEKIREQEEM | 506 | A8MZA4 | |
| KMQEQEETMWRQEEK | 636 | A8MZA4 | |
| QEEKMRRQEEKMWEQ | 696 | A8MZA4 | |
| EQEEQMRKQEEQMWK | 371 | A0A1B0GV03 | |
| MRKQEEQMWKQEEQI | 376 | A0A1B0GV03 | |
| GEQEEQMRKQEEQMW | 391 | A0A1B0GV03 | |
| ELLSWVEEMQMKLER | 591 | Q9UPN3 | |
| VEEMQMKLERAEWGN | 596 | Q9UPN3 | |
| MEKQIWGELETMQNE | 391 | Q96LP2 | |
| WKDDITQDAMIQKME | 116 | Q5W5W9 | |
| MEEGEFKNWIEKMQA | 1456 | Q9Y2I7 | |
| VRIMMNEGKINQSEW | 3531 | Q9P2D7 | |
| DMADVWVKIQDVLQM | 381 | Q96A65 | |
| MEWKLEQSMREQALL | 1 | Q0D2H9 | |
| LERIWGNQIEMMKDR | 751 | A6NNT2 | |
| RSEMEKWVEDIQMAI | 841 | Q9Y4F1 | |
| MENDMKKLVAERDIW | 386 | Q5T1B0 | |
| ETNRENDKQETWMLM | 656 | P15924 | |
| NDKQETWMLMELQKI | 661 | P15924 | |
| ELMRKESQWQMEQEF | 151 | Q9BV73 | |
| WQKKMTQLEMEIQEA | 551 | Q5VZ89 | |
| EEEAMMQEWFMLVNK | 1111 | Q8NDI1 | |
| LDYQDKWVRMQKLEM | 221 | O00754 | |
| EQIMKDRWMNVGHED | 296 | Q7KZI7 | |
| QVDSVQRWMEDLKLM | 71 | Q1MX18 | |
| EMKEMALEAIVQLWR | 516 | Q92538 | |
| EEAQQLWEAEKVKMR | 791 | Q14289 | |
| ADLIDAEQRMKKSMW | 576 | A3KN83 | |
| MVLCNEVTKWMKDDI | 4511 | Q8TE73 | |
| MDLQLEWMKLEDFQK | 536 | Q99549 | |
| WDKLFIMLENSQMRE | 56 | P26022 | |
| LTRRANWMQKDLEEM | 101 | Q9Y283 | |
| EAEEEMQIQKSQWMK | 286 | A1L443 | |
| EAEEEMQIQKSQWMK | 286 | Q5VZR2 | |
| KLWEMDNMLIQIKTQ | 56 | Q9Y605 | |
| NLARIDKMEEEMHKW | 271 | Q96NZ1 | |
| EVWKQMFQELMREVK | 6 | Q9BQQ7 | |
| MMRDWEKFQEEAKNR | 386 | A2RTX5 | |
| KKDLAEMQEWMTQAE | 1131 | P46939 | |
| WQKEEMALKHMQAEL | 771 | Q96R06 | |
| MKQKEQEERMSLWAT | 766 | Q8IWB6 | |
| QLRELMEKVEAIMWE | 211 | Q6P9H5 | |
| SMQDDWKLEIQQMFD | 416 | Q5TCX8 | |
| LVNNWEMDKLEMEDA | 671 | Q9NYY8 | |
| ETLIAKRALMKMWQE | 366 | Q6ZUB1 | |
| DMLKQLEKEWMTQQT | 746 | Q8IYB8 | |
| KLLKTMMWDNVNAED | 871 | Q7Z745 | |
| GRQVDSMWAEQKQME | 76 | P01286 | |
| NVMKRMAWEEIAQCV | 41 | Q8NCY6 | |
| QDVAELMQWMEEKGL | 1321 | Q9NRC6 | |
| VWEKNMKMIELHNQE | 51 | P07711 | |
| ERKEWMQALQQAMAE | 406 | Q96P48 | |
| KQWLNMDEREMENII | 1586 | Q8N3C0 | |
| EESDMWKIRELEKQM | 26 | Q6ZUT1 | |
| KRRQKIEMWDSMQEG | 111 | Q9BQE4 | |
| LLKKQQMLEWEMAVR | 1421 | O15020 | |
| QMLEWEMAVREKEVE | 1426 | O15020 | |
| VRELMLWMDEVNLQM | 1916 | O15020 | |
| LMNTMLIEELQDWKR | 226 | Q14765 | |
| LQMIQLMDVLWKQEG | 791 | O00329 | |
| KKEMMEELVEGVRWA | 431 | P78562 | |
| ARREQVMADVAWMKQ | 316 | Q9BT92 | |
| VMADVAWMKQAIEEQ | 321 | Q9BT92 | |
| LQMLLREEAKEMWEK | 346 | Q9BT92 | |
| QVMSRRKEMNEKWEA | 1986 | P11277 | |
| EKETEELMAWMRNVL | 576 | Q12931 | |
| QWLMPEARSKEQMLE | 76 | Q8TBC5 | |
| NEDSEGKEQRWEMVM | 131 | Q9NQZ5 | |
| KINWAMEDKQEMVDI | 101 | P83876 | |
| RVWDLKDDGNMMKVL | 196 | Q9Y6I7 | |
| QKVWDKEGEMEVAMQ | 56 | Q9H521 | |
| REEKIWMMKTAIQRE | 61 | Q9NZL3 | |
| NDRVKALKAMEMTWN | 506 | P17480 | |
| KFEEWCIEMAEMRKQ | 446 | Q86UV5 | |
| MISQLEREEKLWMKE | 56 | Q14590 | |
| ARMEWKLEQSMREQA | 196 | A6NN73 | |
| EDQWIRIFMEKGDMV | 111 | Q9BV57 |